Immunemodulation in Patients With Minor Head Injury (MHI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00622778
Recruitment Status : Completed
First Posted : February 25, 2008
Last Update Posted : April 11, 2012
Information provided by:
Medical University of Vienna

Brief Summary:
The purpose of this study is to try to prove the worth of the two (2) Serum Proteins S-100 Beta and NSE in combination with a diagnostic algorithm to help to establish diagnosis in patients with minor head injury.

Condition or disease
Head Trauma

Study Type : Observational
Actual Enrollment : 130 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Diagnostic Algorithm in Minor Head Injury
Study Start Date : October 2007
Primary Completion Date : May 2011
Study Completion Date : July 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Head Injuries
U.S. FDA Resources

Patients from daily practice

Primary Outcome Measures :
  1. Intracranial Haematoma [ Time Frame: 2 weeks ]

Biospecimen Retention:   Samples Without DNA
Serum from peripheral blood

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   1 Year and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients from daily practice

Inclusion Criteria:

  • minor head injury

Exclusion Criteria:

  • severe head injury

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00622778

Medical University of Vienna
Vienna, Austria, 1090
Sponsors and Collaborators
Medical University of Vienna
Study Chair: Vilmos Vecsei, M.D. Professor Head of Department